Navigation Links
Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
Date:6/12/2008

while supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453. Additional information may be requested from http://www.repligen.com.

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical statements, including, without limitation, statements regarding current or future financial performance and position, management's strategy, plans and objectives for future operations, plans and objectives for product development, plans and objectives for present and future clinical trials and results of such trials, plans and objectives for regulatory approval, litigation, intellectual property, product development, manufacturing plans and performance such as the anticipated growth in the monoclonal antibody market and our other target markets and projected growth in product sales, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, without limitation, risks associated with: the success of current and future collaborative relationships, the market acceptance of our products, our ability to compete with larger, better financed pharmaceutical and biotechnology companies, new approaches to the treatment of our targeted diseases, our expectation of incurring continued losses, our uncertainty of product revenues and profits, our ability to generate future revenues, our ability to raise additional capital to continue o
'/>"/>

SOURCE Repligen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder
2. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
3. Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Research and Markets ( ... "Medical Device Outsourcing - Global Strategic Business ... This report analyzes the worldwide markets for Medical ... Device Categories: Class I, Class II, and Class ... report Include - Radiology, Orthopedic, Neurology, Cardiology, and ...
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/lmsnqn/medical_equipment ... Equipment Rental and Leasing - Global Strategic Business Report" ... analyzes the worldwide markets for Medical Equipment Rental and ... analytics for the US, Japan , ... Annual estimates and forecasts are provided for ...
(Date:4/17/2015)... , April 17, 2015 ASSESS ... mutation   is a viable alternative to tumour biopsy   ... in all patients with advanced NSCLC   AstraZeneca ... of plasma circulating tumour DNA (ctDNA) testing for epidermal growth ... advanced non-small cell lung cancer (NSCLC) in clinical practice. [ ...
Breaking Medicine Technology:Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 2Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 3Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4
... 2011 OncologyRx Care Advantage, McKesson Specialty Health ... by Incyte Corporation as one of only ... to fill prescriptions for Jakafi (ruxolitinib), an oral prescription ... (Logo:  http://photos.prnewswire.com/prnh/20110912/DA65711LOGO ) ...
... Solos Endoscopy, Inc.,s (OTCPK: SNDY) is pleased to ... Net Profit of $73,895.  Solos Endoscopy has consummated agreements ... for the Three Months period ending September 30, 2011. ... in a reduction of ongoing expenses by approximately $40,000 ...
Cached Medicine Technology:OncologyRx Care Advantage™ Chosen to Fill Prescriptions for Jakafi™ (ruxolitinib) 2Solos Endoscopy Finishes the 3rd Quarter With a Net Profit 2
(Date:4/19/2015)... Family and friends of Brad Baddeley are ... of Brad Baddeley event to honor his memory and ... for Brains is cheduled to take place on Sunday, April ... Lincoln, Nebraska. Participants may arrive at 12:30pm on the 26th ... cost is only $4 per game and 100% of the ...
(Date:4/18/2015)... Hills, CA (PRWEB) April 19, 2015 For ... and will proudly display for the rest of their lives, ... money obtaining them and put in a great amount of ... on a whim, they have outgrown them or simply want ... percent of people regret their tattoo, and in 2012-13 there ...
(Date:4/18/2015)... 2015 Compare-autoinsurance.org has released a new ... auto insurance policy . , Clients should no ... quotes online is safe and reliable. An insurance brokerage ... are displayed on a single web page, so drivers ... It is now possible to compare online car insurance ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Carinsurancesavings.biz has ... insurance plans are cheaper during Spring. , ... auto insurance plan. Drivers should make sure they compare ... their vehicles. Clients can learn more about Spring car ... , Auto insurance quotes are becoming more and ...
(Date:4/18/2015)... PITTSBURGH, PA (PRWEB) April 18, 2015 ... store evacuation stretchers in healthcare facilities," said an inventor ... an alternative storage system." , He developed the Slyde ... bathroom doors used in healthcare facilities. It provides convenient ... that there are more stretchers available for patients. ...
Breaking Medicine News(10 mins):Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:A Guide For Avoiding Online Auto Insurance Scams! 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2
... new and efficient strategy, using eggs alone, for creating ... the risk of rejection because the cells are compatible ... mice, the work establishes the principle of using unfertilized ... that are genetically matched to the egg donor at ...
... infected with lymphocytic choriomeningitis virus (LCMV), an infectious agent ... cause severe brain damage in a fetus. ... winter months, when rodents seek shelter in homes, said ... the University of Iowa Roy J. and Lucille A. ...
... Hospital reporting systems may significantly under-report patient safety incidents, ... on bmj.com today//. ,The authors suggest that the ... be sufficient if the NHS is to gather accurate ... safety incidents. ,Patient safety incidents are common ...
... could bankrupt the health system, warn doctors in this week’s ... population is overweight and more than one in five adults ... at high risk of multiple health problems, while the cost ... at up to 9%, and the overall social cost of ...
... past two decades are leading to more definitive diagnoses, ... for patients suffering from a condition called acromegaly. ... for Academic Affairs and director of the Burns and ... medical progress related to the condition that stems from ...
... vaccine, will hold a pride of place in the annals ... to receive certification by the European Medicines Agency, for its ... bird-flu pandemic. , ,This first generation vaccine can ... officially declares a pandemic. ,A second –generation vaccine ...
Cached Medicine News:Health News:Researchers Create Genetically-Matched Embryonic Stem Cells for Transplantation 2Health News:Researchers Create Genetically-Matched Embryonic Stem Cells for Transplantation 3Health News:Pregnant Women Can Minimize Risk Of Rodent-Based Virus 2Health News:Hospitals Miss Most Patient Safety Incidents 2Health News:Obesity Could Bankrupt the Health System, Warn Doctors 2Health News:Options Improving for Patients With Acromegaly and Gigantism 2Health News:Options Improving for Patients With Acromegaly and Gigantism 3
The DBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of direct (conjugated) bilirubin in serum and plasma....
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum...
Latex agglutination slide test for the qualitative and semi-quantitative determination of Anti-Streptolysin O (ASO) in human serum...
For the quantitative in vitro determination of IgA in serum and plasma. This product is suitable for use on Hitachi 704, 705, 717, 902, 911 and 912....
Medicine Products: